This result may seem contradictory, since, in a previous study, we reported an increase in the expression of hepatic OLFM2 mRNA in patients with NASH and in subjects with lobular inflammation [19]. This evidence concerns the gene OLFM2 and metabolic dysfunction-associated steatohepatitis.